UROV insider filings
Urovant Sciences Ltd. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-03-31. Screen UROV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for UROV between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Urovant Sciences Ltd.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-03-31 | 4 | Haag-Molkenteller Cornelia — CMO/Urovant Sciences, Inc. | Disposition to issuer (D): 11,603 · Disposition to issuer (D): 129,745 · Disposition to issuer (D): 146,850 (derivative) @ $0 · Disposition to issuer (D): 1,000 (derivative) @ $0 · Disposition to issuer (D): 100,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Kurstjens Sef — Director | Disposition to issuer (D): 12,480 · Disposition to issuer (D): 9,000 · Disposition to issuer (D): 13,350 (derivative) @ $0 · Disposition to issuer (D): 36,650 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Johnston Walt — See Remarks | Disposition to issuer (D): 492 · Disposition to issuer (D): 108,647 · Disposition to issuer (D): 69,197 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Smith Bryan E. — GC/Urovant Sciences, Inc. | Disposition to issuer (D): 9,341 · Disposition to issuer (D): 115,106 · Disposition to issuer (D): 93,450 (derivative) @ $0 · Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Robinson James A. Jr. — PEO;CEO/Urovant Sciences, Inc., Director | Disposition to issuer (D): 8,385 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 845,732 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Hindman James M. — Director | Disposition to issuer (D): 9,000 · Disposition to issuer (D): 61,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | Legault Pierre — Director | Disposition to issuer (D): 12,480 · Disposition to issuer (D): 9,000 · Disposition to issuer (D): 13,350 (derivative) @ $0 · Disposition to issuer (D): 36,650 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | OCAMPO CHRISTINE — PAO; CAO/Urovant Sciences,Inc. | Disposition to issuer (D): 9,810 · Disposition to issuer (D): 68,971 · Disposition to issuer (D): 133,500 (derivative) @ $0 · Disposition to issuer (D): 3,750 (derivative) @ $0 · Disposition to issuer (D): 70,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | BANSAL AJAY — See Remarks | Disposition to issuer (D): 24,876 · Disposition to issuer (D): 115,222 · Disposition to issuer (D): 140,000 (derivative) @ $0 | EDGAR |
| 2021-03-31 | 4 | POTTER MYRTLE S — Director | Disposition to issuer (D): 12,480 · Disposition to issuer (D): 9,000 · Disposition to issuer (D): 50,000 (derivative) @ $0 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 | EDGAR |
| 2021-01-12 | 4 | Robinson James A. Jr. — PEO; CEO/Urovant Sciences, Inc, Director | Tax withholding (F): 4,095 @ $16.11 | EDGAR |
| 2021-01-08 | 4 | Haag-Molkenteller Cornelia — CMO/Urovant Sciences, Inc. | Tax withholding (F): 5,810 @ $16.09 | EDGAR |
| 2021-01-08 | 4 | Smith Bryan E. — GC/Urovant Sciences, Inc. | Tax withholding (F): 4,761 @ $16.09 | EDGAR |
Recent 8-K events — Urovant Sciences Ltd.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-03-29 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-03-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2021-02-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-12-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-24 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-17 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2020-11-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-02 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=UROV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs